ERIC LYAKHOVETSKY: Open Payments
NPI 1134780851 · BLOOMINGTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$392 in 7 payments from 5 companies in 2025. Trend: 2023 $138 · 2024 $419 · 2025 $392
Food & beverage: $392
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 1 | $127 |
| E.R. Squibb & Sons, L.L.C. | 2 | $110 |
| Vanda Pharmaceuticals Inc. | 1 | $88 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| Axsome Therapeutics, Inc. | 1 | $28 |
Products named: LYBALVI, COBENFY, FANAPT, UZEDY, Auvelity.
Industry payments across IN — which companies pay providers there.
